Article
Zebrafish Model Reveals Early Electrocardiographic and Molecular Signatures of Doxorubicin-Induced Cardiotoxicity.
Cardiovascular toxicology - 13 Apr 2026
Lai Zih-Yin, Lee Chi-Ying, Chiu Yu-Ching, Lin Chia-Hung, Yang Chung-Chi, Ho Chia-Chia, Liu Lawrence Yu-Min, Chuang Yung-Jen
Abstract excerpt
Doxorubicin (DOX) is a highly effective anthracycline widely used in cancer therapy but limited by its dose-dependent cardiotoxicity, which may result in arrhythmia, dilated cardiomyopathy, and heart failure. Conventional surveillance tools, including echocardiography and serum biomarkers, often identify injury only after substantial cardiac dysfunction has occurred. This underscores the need for early markers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
